Scholar : Acta Oncologica, Volume 55, Issue 9-10, September - October 2016 is now available online on Taylor & Francis Online

The online platform for Taylor & Francis Online content Acta Oncologica, Volume 55, Issue 9-10, September - October 2016 is now available online on Taylor & Francis Online. This new issue contains the following articles: EDITORIAL Tell all the good news as soon as possible Bengt Glimelius Pages: 1067-1068 | DOI: 10.1080/0284186X.2016.1229868 REVIEWS Effect of calculation method on kidney dosimetry in 177Lu-octreotate treatment Jorma Heikkonen, Hanna Mäenpää, Eero Hippeläinen, Vappu Reijonen & Mikko Tenhunen Pages: 1069-1076 | DOI: 10.1080/0284186X.2016.1182642 First line treatment with newer tyrosine kinase inhibitors in chronic myeloid leukemia associated with deep and durable molecular response – systematic review and meta-analysis Ronit Gurion, Pia Raanani, Liat Vidal, Avi Leader & Anat Gafter-Gvili Pages: 1077-1083 | DOI: 10.1080/0284186X.2016.1201214 ORIGINAL ARTICLES: Head and neck cancer Trends in all-cause five-year mortality after head and neck cancers diagnosed over a period of 33 years. Focus on estimated degree of association with human papillomavirus Malene F. Svahn, Christian Munk, Thor S. S. Nielsen, Christian von Buchwald, Kirsten Frederiksen & Susanne K. Kjaer Pages: 1084-1090 | DOI: 10.1080/0284186X.2016.1185148 Validation of a 15-gene hypoxia classifier in head and neck cancer for prospective use in clinical trials Kasper Toustrup, Brita Singers Sørensen, Mohamed A. Hassan Metwally, Trine Tramm, Lise Saksø Mortensen, Jens Overgaard & Jan Alsner Pages: 1091-1098 | DOI: 10.3109/0284186X.2016.1167959 Influence of FDG-PET on primary nodal target volume definition for head and neck carcinomas Sylvia L. van Egmond, Vera Piscaer, Luuk M. Janssen, Inge Stegeman, Monique G. Hobbelink, Wilko Grolman & Chris H. Terhaard Pages: 1099-1106 | DOI: 10.1080/0284186X.2016.1182643 Risk of lymph node metastasis and recommendations for elective nodal treatment in squamous cell carcinoma of the nasal cavity and maxillary sinus: a SEER analysis Peter H. Ahn, Nandita Mitra, Michelle Alonso-Basanta, James N. Palmer, Nithin D. Adappa, Bert W. O'Malley Jr., Christopher Rassekh, Ara Chalian, Roger B. Cohen & Alexander Lin Pages: 1107-1114 | DOI: 10.1080/0284186X.2016.1216656 ORIGINAL ARTICLES: Haematological malignancies Health-related quality of life and patient-reported outcomes of ofatumumab plus chlorambucil versus chlorambucil monotherapy in the COMPLEMENT 1 trial of patients with previously untreated CLL Peter Hillmen, Ann Janssens, K. Govind Babu, Janusz Kloczko, Sebastian Grosicki, Stephanie Manson, Astrid McKeown, Ira Gupta, Chai-Ni Chang & Fritz Offner Pages: 1115-1120 | DOI: 10.1080/0284186X.2016.1205217 Neurocognitive function of lymphoma patients after treatment with chemotherapy Hans Wouters, Joke W. Baars & Sanne B. Schagen Pages: 1121-1125 | DOI: 10.1080/0284186X.2016.1189092 A population-based study of cellular markers in R-CHOP treated diffuse large B-cell lymphoma patients Maysaa Abdulla, Sofia Laszlo, Johanna Triumf, Gustaf Hedström, Mattias Berglund, Gunilla Enblad & Rose-Marie Amini Pages: 1126-1131 | DOI: 10.1080/0284186X.2016.1189093 Proton pencil beam scanning for mediastinal lymphoma: treatment planning and robustness assessment Chuan Zeng, John P. Plastaras, Paul James, Zelig A. Tochner, Christine E. Hill-Kayser, Stephen M. Hahn & Stefan Both Pages: 1132-1138 | DOI: 10.1080/0284186X.2016.1191665 Sporadic occurrence of non-diagnosed IgG4-related disease in lymphoma patients with a previous Sjögren's syndrome diagnosis Lilian Vasaitis, Christer Sundström, Carin Backlin, Gunnel Nordmark & Eva Baecklund Pages: 1139-1144 | DOI: 10.1080/0284186X.2016.1182644 ORIGINAL ARTICLES: Paediatric oncology Pediatric bone tumors in Germany from 1987 to 2011: incidence rates, time trends and survival Peter Kaatsch, Jill Strothotte, Cornelia Becker, Stefan Bielack, Uta Dirksen & Maria Blettner Pages: 1145-1151 | DOI: 10.1080/0284186X.2016.1195509 Parents of children diagnosed with cancer: work situation and sick leave, a five-year post end-of-treatment or a child's death follow-up study Anna Wikman, Emma Hovén, Martin Cernvall, Gustaf Ljungman, Lisa Ljungman & Louise von Essen Pages: 1152-1157 | DOI: 10.3109/0284186X.2016.1167956 ORIGINAL ARTICLES: Gastrointestinal cancer More deaths from pancreatic cancer than breast cancer in the EU by 2017 J. Ferlay, C. Partensky & F. Bray Pages: 1158-1160 | DOI: 10.1080/0284186X.2016.1197419 Improvement in survival for patients with synchronous metastatic esophageal cancer in the south of the Netherlands from 1994 to 2013 N. Bernards, N. Haj Mohammad, G. J. Creemers, T. Rozema, J. A. Roukema, G. A. P. Nieuwenhuijzen, H. W. M. van Laarhoven, M. van der Sangen & V. E. P. P. Lemmens Pages: 1161-1167 | DOI: 10.1080/0284186X.2016.1176249 Efficacy of a sequential treatment strategy with GEMOX-based followed by FOLFIRI-based chemotherapy in advanced biliary tract cancers Sihem Sebbagh, Julia Roux, Chantal Dreyer, Cindy Neuzillet, Armand de Gramont, Cecilia Orbegoso, Olivia Hentic, Pascal Hammel, Aimery de Gramont, Eric Raymond, Thierry André, Benoist Chibaudel & Sandrine Faivre Pages: 1168-1174 | DOI: 10.1080/0284186X.2016.1191670 Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab Kristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, Per Pfeiffer & Helle Westergren Hendel Pages: 1175-1182 | DOI: 10.3109/0284186X.2016.1170197 Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands Laura M. Legué, Nienke Bernards, Sophie L. Gerritse, Thijs R. van Oudheusden, Ignace H. J. T. de Hingh, Geert-Jan M. Creemers, Albert J. ten Tije & Valery E. P. P. Lemmens Pages: 1183-1189 | DOI: 10.1080/0284186X.2016.1182211 ORIGINAL ARTICLES: Supportive care Malignancy associated SIADH: Characterization and clinical implications H. Goldvaser, B. Rozen-Zvi, R. Yerushalmi, A. Gafter-Gvili, M. Lahav & D. Shepshelovich Pages: 1190-1195 | DOI: 10.3109/0284186X.2016.1170198 Risk of hyperglycemia attributable to everolimus in cancer patients: A meta-analysis Kevin Y. Xu, Raji Shameem & Shenhong Wu Pages: 1196-1203 | DOI: 10.3109/0284186X.2016.1168939 Self-rated health and cancer risk – a prospective cohort study among Danish women Ida Kristiane Roelsgaard, Anne Marie Olesen, Mette Kildevæld Simonsen & Christoffer Johansen Pages: 1204-1209 | DOI: 10.1080/0284186X.2016.1210822 Effectiveness of a tailored return to work program for cancer survivors with job loss: results of a randomized controlled trial M. P. van Egmond, S. F. A. Duijts, M. A. Jonker, A. J. van der Beek & J. R. Anema Pages: 1210-1219 | DOI: 10.1080/0284186X.2016.1213417 Asking the right questions to get the right answers: using cognitive interviews to review the acceptability, comprehension and clinical meaningfulness of patient self-report adverse event items in oncology patients | Patricia Holch, Lorraine Warrington, Barbara Potrata, Lucy Ziegler, Ceri Hector, Ada Keding, Clare Harley, Kate Absolom, Carolyn Morris, Leon Bamforth & Galina Velikova Pages: 1220-1226 | DOI: 10.1080/0284186X.2016.1213878 Oxaliplatin added to fluoropyrimidine for adjuvant treatment of colorectal cancer is associated with long-term impairment of peripheral nerve sensory function and quality of life Måns Stefansson & Peter Nygren Pages: 1227-1235 | DOI: 10.1080/0284186X.2016.1197420 LETTERS TO THE EDITOR Symptomatic spinal metastasis from intracranial glioblastoma multiforme – Two illustrative cases and a review of the literature Mercy Varghese, Hanne Gjertsen Nymoen, Cathrine Saxhaug, Bård Krossnes, Sayied Abdol Mohieb Hosainey, Torstein R. Meling & Petter Brandal Pages: 1236-1238 | DOI: 10.3109/0284186X.2016.1161824 Tailored nurse navigation for women treated for breast cancer: Design and rationale for a pilot randomized controlled trial Pernille Envold Bidstrup, Birgitte Goldschmidt Mertz, Niels Kroman, Michael Andersson, Ulla Breitenstein Mathiesen, Jette Vibe-Petersen, Susanne Oksbjerg Dalton & Christoffer Johansen Pages: 1239-1243 | DOI: 10.3109/0284186X.2016.1167957 Dosimetric feasibility of single-energy proton modulated arc therapy for treatment of chordoma at the skull base Janid Patricia Blanco Kiely & Benjamin M. White Pages: 1243-1245 | DOI: 10.3109/0284186X.2016.1170199 Muscle satellite cell content and mRNA signaling in germ cell cancer patients – effects of chemotherapy and resistance training J. F. Christensen, P. Schjerling, J. L. Andersen, G. Daugaard, M. Rørth & A. L. Mackey Pages: 1246-1250 | DOI: 10.3109/0284186X.2016.1170200 Delayed anastomotic leakage following bevacizumab administration in colorectal cancer patients Mehrdad Jafari, Williams Tessier, Farid El Hajbi, Gauthier Decanter & Xavier Mirabel Pages: 1250-1252 | DOI: 10.3109/0284186X.2016.1171393 Concerns of low-risk thyroid cancer survivors Anna M. Sawka, Richard W. Tsang, James D. Brierley, Lorne Rotstein, Phillip Segal, Shereen Ezzat & David P. Goldstein Pages: 1252-1253 | DOI: 10.1080/0284186X.2016.1175661 BOOK REVIEW Book review of "A history of hematology: from Herodotus to HIV", Shaun R. McCann, Oxford Medical Histories Magnus Björkholm Pages: 1254-1254 | DOI: 10.1080/0284186X.2016.1201217 Corrigenda Corrigendum Pages: 1255-1255 | DOI: 10.1080/0284186X.2016.1176731 Corrigendum Pages: 1256-1256 | DOI: 10.1080/0284186X.2016.1234138 Have you discovered our Medical Facebook page yet? Check it out for the latest news, free access content and much more. This message is personalised to your status as a society member. Please do not forward this email. To recommend content, please use the social sharing tools on the website. To update which email alerts you receive, manage your alerts within the My Account area. You can also unsubscribe from this alert with one click. If you need any further help, please contact us at support@tandfonline.com Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list. Taylor & Francis, an Informa business. Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.